The role of p53 in tumour suppression: lessons from mouse models

被引:154
作者
Attardi, LD [1 ]
Jacks, T
机构
[1] MIT, Ctr Canc Res, Cambridge, MA 02139 USA
[2] MIT, Dept Biol, Cambridge, MA 02139 USA
[3] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA
关键词
p53; mouse model; tumour suppressor gene; cancer; apoptosis cell-cycle arrest;
D O I
10.1007/s000180050269
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of mouse models has greatly contributed to our understanding of the role of p53 in tumour suppression. Mice homozygous for a deletion in the p53 gene develop tumours at high frequency, providing essential evidence for the importance of p53 as a tumour suppressor. Additionally, crossing these knockout mice or transgenic expression p53 dominant negative alleles with other tumour-prone mouse strains has allowed the effect of p53 loss on tumour development to be examined further. In a variety of mouse models, absence of p53 facilitates tumorigenesis, thus providing a means to study how the lack of p53 enhances tumour development and to define genetic pathways of p53 action. Depending on the particular model system, loss of p53 either results in deregulated cell-cylce entry or aberrant apoptosis (programmed cell death), confirming results found in cell culture systems and providing insight into in vitro function of p53. Finally, as p53 null mice rapidly develop tumours, they are useful for evaluating agents for either chemopreventative or therapeutic activities.
引用
收藏
页码:48 / 63
页数:16
相关论文
共 88 条
[61]   P53 AND THE LI-FRAUMENI SYNDROME [J].
MALKIN, D .
CANCER GENETICS AND CYTOGENETICS, 1993, 66 (02) :83-92
[62]  
MARIN MC, 1994, ONCOGENE, V9, P3107
[63]   K-RAS MUTATIONS IN LUNG-TUMORS FROM A/J AND A/JXTSG-P53 F1-MICE TREATED WITH 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND PHENETHYL ISOTHIOCYANATE [J].
MATZINGER, SA ;
CRIST, KA ;
STONER, GD ;
ANDERSON, MW ;
PEREIRA, MA ;
STEELE, VE ;
KELLOFF, GJ ;
LUBET, RA ;
YOU, M .
CARCINOGENESIS, 1995, 16 (10) :2487-2492
[64]   Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors [J].
McClatchey, AI ;
Saotome, I ;
Mercer, K ;
Crowley, D ;
Gusella, JF ;
Bronson, RT ;
Jacks, T .
GENES & DEVELOPMENT, 1998, 12 (08) :1121-1133
[65]  
MIYASHITA T, 1995, CELL, V80, P293
[66]  
MIYASHITA T, 1994, ONCOGENE, V9, P1799
[67]   REARRANGEMENTS OF THE CELLULAR P53 GENE IN ERYTHROLEUKAEMIC CELLS TRANSFORMED BY FRIEND-VIRUS [J].
MOWAT, M ;
CHENG, A ;
KIMURA, N ;
BERNSTEIN, A ;
BENCHIMOL, S .
NATURE, 1985, 314 (6012) :633-636
[68]   MECHANISMS OF P53 LOSS IN HUMAN SARCOMAS [J].
MULLIGAN, LM ;
MATLASHEWSKI, GJ ;
SCRABLE, HJ ;
CAVENEE, WK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) :5863-5867
[69]  
Nacht M, 1998, CELL GROWTH DIFFER, V9, P131
[70]   Mutations in the p53 and SCID genes cooperate in tumorigenesis [J].
Nacht, M ;
Strasser, A ;
Chan, YR ;
Harris, AW ;
Schlissel, M ;
Bronson, R ;
Jacks, T .
GENES & DEVELOPMENT, 1996, 10 (16) :2055-2066